about
Melanocytes in the skin--comparative whole transcriptome analysis of main skin cell typesNRP1 function and targeting in neurovascular development and eye diseaseTransmembrane recognition of the semaphorin co-receptors neuropilin 1 and plexin A1: coarse-grained simulationsVEGF targets the tumour cell.Assay development for the discovery of semaphorin 3B inducing agents from natural product sources.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Breast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro.Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retinaExpression of VEGF and semaphorin genes define subgroups of triple negative breast cancerAxon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinomaClass 3 semaphorins in cardiovascular development.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity.The role of semaphorins and their receptors in vascular development and cancer.The potential of class 3 semaphorins as both targets and therapeutics in cancer.Identification of Osr2 Transcriptional Target Genes in Palate Development.Transmembrane semaphorins, forward and reverse signaling: have a look both ways.Semaphorins and their Signaling Mechanisms.Therapeutic application of anti-angiogenic nanomaterials in cancers.Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion.Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk.Angioneural crosstalk in scaffolds with oriented microchannels for regenerative spinal cord injury repair.The microRNA regulatory landscape of MSC-derived exosomes: a systems view.Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress GBM Tumor Growth.Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.Semaphorin 3A promotes osteogenic differentiation in human alveolar bone marrow mesenchymal stem cells.Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma.
P2860
Q21131830-C8DA3E27-351D-4C86-BC68-986043A92A8AQ26765952-2B0B7475-2F7F-48C0-912A-2FEF83B8F61BQ28539091-FCE87021-6696-4232-8276-768D738403CBQ33573324-43D2DEA6-71AC-4E43-9ADD-586058BE607AQ34337052-1DE85A78-4371-4751-876C-F6318356E304Q34427193-41163E9C-1D02-4C85-A73F-481180D887BBQ35406039-5CA881EB-8939-42C6-8AAE-E9D6CBBC0204Q35764986-458054AA-913D-47D6-8206-5F01A27DB82AQ35952075-4E5D3667-5AA6-4DCF-87C6-9B4FA2E4917BQ36236304-676FB7D6-ABC4-4D94-BA90-DC1C09ABD78FQ36533995-B408072E-2055-4CB8-B798-C0D030CAAD31Q36828220-E7B57194-2C8C-4412-B335-573FF39648D1Q36905839-8D460DDD-AB68-404A-A021-E09C67764442Q37509074-5CD7F329-D09D-41AA-BC35-9D676C0444E5Q38022543-615537B6-0FBE-443E-B263-BA7069B6E4BCQ38040614-CBB9AE3B-88AC-44D7-B05C-4CD6A8062CF1Q38082866-6FD00D34-BF18-41D5-8724-371C75D53453Q38272709-ACA465B6-E3FA-4AA6-9F0F-2318B4A14E8EQ38430882-14F81DF9-7755-4EC7-B2B2-8C4BBE6C8DECQ38705860-0D099FFF-A4CC-43AF-9478-3EA2C59F74ACQ38804261-FCCA2528-0286-4226-967A-8E1AE984EC64Q38805034-DFFEE1FC-5332-466A-B023-313E9E6FCDC4Q39029459-92AD7F31-BC43-4AB3-987B-CB2652F9F99AQ41258130-BBFC2514-04B5-40E9-836D-E9C818F2213EQ43171711-B89D7BBD-8F04-43F4-A067-84ECB9974166Q44262764-2DB4193E-5E6B-4F4A-80F0-4BA0526C6B62Q47549516-0E5C1A7B-F840-4A00-84E9-E97619A37BD8Q47612046-48B1960E-890B-4926-8CCE-B291454EF440Q50009957-2C775153-0628-4225-9BBB-7CCF5D2D2318Q51733552-FD98F1C4-6C38-45E8-A89A-D66B461D0310Q55397591-D88F5846-AB31-4385-B151-C781685EE738
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Semaphorins in angiogenesis and tumor progression.
@ast
Semaphorins in angiogenesis and tumor progression.
@en
type
label
Semaphorins in angiogenesis and tumor progression.
@ast
Semaphorins in angiogenesis and tumor progression.
@en
prefLabel
Semaphorins in angiogenesis and tumor progression.
@ast
Semaphorins in angiogenesis and tumor progression.
@en
P2093
P2860
P1476
Semaphorins in angiogenesis and tumor progression.
@en
P2093
Adi D Sabag
Gera Neufeld
Noa Rabinovicz
Ofra Kessler
P2860
P304
P356
10.1101/CSHPERSPECT.A006718
P577
2012-01-01T00:00:00Z